Dec 31, 2018

Gilead Sciences Q4 2018 Earnings Report

Total Revenue
$5.8B
Previous year: $5.95B
-2.6%
EPS
$1.44
Previous year: $1.78
-19.1%
Gross Profit
$4.23B
Previous year: $4.69B
-10.0%
Cash and Equivalents
$17.9B
Previous year: $7.59B
+136.4%
Free Cash Flow
$2.1B
Total Assets
$63.7B
Previous year: $70.3B
-9.4%

Gilead Sciences

Gilead Sciences

Gilead Sciences Revenue by Segment

Gilead Sciences Revenue by Geographic Location

Revenue & Expenses

Visualization of income flow from segment revenue to net income